Do flax lignans have misknown benefits?;Les lignanes phytoestrogènes du lin sont-ils des bienfaiteurs méconnus?

Phytotherapie

Volumn 5, Issue 3, 2007, Pages 121-128

  Laine E ^a   Hano, C ^a   Lamblin, F ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Antioxydant; Flax; Lignan; Linum usitatissimum; Phytoestrogen

Indexed keywords

LIGNAN; SEX HORMONE;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; DRUG MECHANISM; HUMAN; IN VITRO STUDY; PROSTATE CANCER; TUMOR GROWTH;

EID: 34548742880     PISSN: 16248597     EISSN: 17652847     Source Type: Journal    
DOI: 10.1007/s10298-007-0237-3     Document Type: Article

References (48)

1. Adlercreutz H, Fotsis T, Heikkinen R, et al. (1982) Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 8311: 1295-1299
2. Adlercreutz H, Bannwart C, Wahala K, et al. (1993) Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44: 147-153
3. Bhathena SJ, Velasquez MT (2002) Beneficial role of dietary phytoes-trogens in obesity and diabetes. Am J Clin Nutr 76(6): 1191-1201
4. Brooks JD, Thompson LU (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94(5): 461-467
5. Bylund A, Saarinen N, Zhang JX, et al. (2005) Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo. Exp Biol Med (Maywood) 230(3): 217-223
6. Chen J, Thompson LU (2003) Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion, and migration in vitro. Br Can Res and Treat 80: 163-170
7. Chen J, Tan KP, Ward WE, et al. (2003) Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. Exp Biol Med (Maywood) 228: 951-958
8. Clark WF, Muir AD, Westcott ND, et al. (2000) A novel treatment for lupus nephritis: lignan precursor derived from flax. Lupus 9(6): 429-436
9. Craigo J, Callahan M, Huang RC, et al. (2000) Inhibition of human papillomavirus type 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives. Antiviral Res 47(1): 19-28
10. Danbara N, Yuri T, Tsujita-Kyutoku M, et al. (2005) Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo. Anticancer Res 25(3B): 2269-2276
11. Demark-Wahnefried W, Price DT, Polascik TJ, et al. (2001) Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58: 47-52
12. Demark-Wahnefried W, Robertson CN, Walther PJ, et al. (2004) Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology 63: 900-904
13. Goodnough JB (2005) Antitumorigenic Effects of Flaxseed and Its Lignan, Secoisolariciresinol Diglycoside (SDG) 10 (1) Nutrition Bytes Article 4
14. Ingram D, Sanders K, Kolybaba M, et al. (1997) Case control study of phyto-oestrogens and breast cancer. Lancet 350: 990-994
15. Kilkkinen A, Virtamo J, Virtanen MJ, et al. (2003) Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1): 1209-1212
16. Kilkkinen A, Virtamo J, Vartiainen E, et al. (2004) Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 108(2): 277-280
17. Kilkkinen A, Erlund I, Virtanen MJ, et al. (2006) Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers. Am J Epidemiol 15 163(8): 687-693
18. Kitts DD, Yuan YV, Wijewickreme AN, et al. (1999) Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202: 91-100
19. Kuijsten A, Arts IC, van't Veer P, et al. (2005) The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed. J Nutr 135(12): 2812-2816
20. Kuijsten A, Arts IC, Vree TB, et al. (2005) Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135(4): 795-801
21. Li D, Yee JA, Thompson LU, et al. (1999) Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice. Cancer Lett 142: 91-96
22. Magee PJ, McGlynn H, Rowland IR (2004) Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett 208: 35-41
23. McCann SE, Kulkarni S, Trevisan M, et al. (2006) Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat 99: 309-311
24. Martin ME, Haourigui M, Pelissero C, et al. (1996) Interactions between phytoestrogens and human sex steroid binding protein. Life Sci 58(5): 429-436
25. Muir AD (2006) Flax lignans-analytical methods and how they influence our lunderstanding of biological activity. J AOAC Int J 89(4): 1147-1157
26. Olsen A, Knudsen KE, Thomsen BL, et al. (2004) Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 13(12): 2084-2089
27. Oomah BD (2001). Flaxseed as a functional food source. J Sci Food Agric 81: 889-894
28. Pietinen P, Stumpf K, Mannisto S, et al. (2001) Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 10(4): 339-344
29. Pool-Zobel BL, Adlercreutz H, Glei M, et al. (2000) Isoflavonoids and lignans have different potentials to modulate oxidative genetic damage in human colon cells. Carcinogenesis 21: 1247-1252
30. Prasad K (1997) Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside isolated from flax-seed. Mol Cell Biochem 168: 117-123
31. Prasad K (1999) Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99: 1355-1362
32. Prasad K (2000) Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: effect of secoisolariciresinol diglucoside (SDG). Mol Cell Biochem 209: 89-96
33. Rajesha J, Murthy KN, Kumar MK, et al. (2006) Antioxidant potentials of flaxseed by in vivo model. J Agric Food Chem 31 54(11): 3794-3799
34. Renault B, Catroux P (2003) The use of lignans for preventing or treating the signs of ageing of the skin. Brevet mondial déposé par L'Oréal. WO2004/010965
35. Renault B, Catroux P (2003) Cosmetic use of lignans. Brevet mondial déposé par L'Oréal. WO2004/012697
36. Saarinen NM, Huovinen R, Warri A, et al. (2002) Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat. Mol Cancer Ther 1: 869-876
37. Schottner M, Spiteller G (1998) Lignans interfering with 5alpha-dihydrotestosterone binding to human sex hormone-binding globulin. J Nat Prod 61: 119-121
38. Shashi B, Jaswant S, Madhusudana RJ, et al. (2006) A novel lignan composition from Cedrus deodara induces apoptosis and early nitric oxide generation in human leukemia Molt-4 and HL-60 cells. Nitric Oxide 14(1): 72-88
39. Smith AY, Feddersen RM, Gardner KD Jr, et al. (1994) Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report. J. Urol 152: 2089-2091
40. Spence JD, Thornton T, Muir AD, et al. (2003) The effect of flax seed cultivars with differing content of alpha-linolenic acid and lignans on responses to mental stress. J Am Coll Nutr 22(6): 494-501
41. Stattin P, Bylund A, Biessy C, et al. (2004) Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 15(10): 1095-1102
42. Tan KP, Chen J, Ward WE, et al. (2004) Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med (Maywood) 229: 147-157
43. Vanharanta M, Voutilainen S, Lakka TA, et al. (1999) Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 9196: 2112-2115
44. Vanharanta M, Voutilainen S, Rissanen TH, et al. (2003). Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 163(9): 1099-1104
45. Van der Schouw YT, Sampson L, Willett WC, et al. (2005) The usual intake of lignans but not that of isoflavones may be related to cardiovascular risk factors in US men. J Nutr 135(2): 260-266
46. Whitten PL, Patisaul HB (2001) Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect 109: 5-20
47. Zeleniuch-Jacquotte A, Adlercreutz H, Manepere lin auteur et al. (2004) Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 5 91(1): 99-105
48. Zeleniuch-Jacquotte A, Lundin E, Micheli A, et al. (2006) Circulating enterolactone and risk of endometrial cancer. Int J Cancer 15 119(10): 2376-2381